Business Wire

TAMPA, Fla.--(BUSINESS WIRE)-- Overseas Shipholding Group, Inc. (NYSE: OSG) (the “Company” or “OSG”), a leading provider of liquid bulk transportation services in the energy industry for crude oil and petroleum products in the U.S. Flag markets, today reported results for the first quarter of 2024.

• Net income for the first quarter of 2024 was $14.6 million, or $0.19 per diluted share, compared to net income of $12.1 million, or $0.14 per diluted share,... (continue reading...)

LONDON--(BUSINESS WIRE)-- Soho House & Co Inc. (NYSE: SHCO) (“SHCO,” “Company,” “we” or “our”), a global membership platform that connects a vibrant, diverse, and global group of members, today announced results for the first quarter ended March 31, 2024.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240510653430/en/

Soho House's White City House in London, UK. Photo: Felix Speller

First... (continue reading...)

First Quarter 2024 Highlights

• 311 homes closed, resulting in revenue, net of sales discounts, of $100.8 million
• Average sale price ("ASP") of production-built homes was approximately $335,000 compared to $314,000 in Q1 2023
• 384 net new home orders in Q1 2024 compared to 389 net new home orders in Q1 2023
• Active community count of 63 as of March 31, 2024
• Approximately 10,900 lots owned or controlled by the Company or affiliates as of March 31,... (continue reading...)

The Property Shop is the second large woman-owned brokerage to move to Real this month

TORONTO & NEW YORK--(BUSINESS WIRE)-- The Real Brokerage Inc. (NASDAQ: REAX), the fastest-growing, publicly traded real estate brokerage, today announced that The Property Shop, led by Season Ware, has joined the company under Real’s Private Label program. Fort Worth’s largest independent brokerage, The Property Shop, brings more than 125 agents with annual home sales... (continue reading...)

Presented favorable safety data from Phase 1/2 NGN-401 gene therapy trial for Rett syndrome at ASGCT Annual Meeting

Received Australian HREC approval for NGN-401 trial

Remains on track to provide interim NGN-401 efficacy data from Cohort 1 in 4Q:24

Strong balance sheet with cash runway into 2H:26

NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families... (continue reading...)